Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Xin-Ping Zhou, Xiu-Jin Ye, Jian-Ping Shen, Jian-Ping Lan, Hui-Fang Jiang, Jin Zhang, Xue-Jin Zhang, Li Li, Shen-Xian Qian & Hong-Yan Tong. (2018) Salvage tigecycline in high risk febrile neutropenic patients with hematological malignancies: a prospective multicenter study. Leukemia & Lymphoma 59:11, pages 2679-2685.
Read now
Read now
Joshua T. Thaden, Jason M. Pogue & Keith S. Kaye. (2017) Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae. Virulence 8:4, pages 403-416.
Read now
Read now
Tina Q Tan & Ram Yogev. (2008) Clinical pharmacology of linezolid: an oxazolidinone antimicrobial agent. Expert Review of Clinical Pharmacology 1:4, pages 479-489.
Read now
Read now
Garyphallia Poulakou & Helen Giamarellou. (2008) Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens. Expert Opinion on Investigational Drugs 17:5, pages 749-771.
Read now
Read now
Melanie Gilson, Laurence Moachon, Luc Jeanne, Valerie Dumaine, Luc Eyrolle, Philippe Morand, Mona Ben M'rad & Dominique Salmon. (2008) Acute pancreatitis related to tigecycline: Case report and review of the literature. Scandinavian Journal of Infectious Diseases 40:8, pages 681-683.
Read now
Read now
Georgios Pappas, Photini Papadimitriou, Leonidas Christou & Nikolaos Akritidis. (2006) Future trends in human brucellosis treatment. Expert Opinion on Investigational Drugs 15:10, pages 1141-1149.
Read now
Read now
Articles from other publishers (56)
Qinghai Tan, Yu Zhang, Mei Liu, De'an Tian, Xiaohui Wu, Lei Zhou & Wenjuan Fan. (2023) Clinical characteristics and risk factors for tigecycline‐induced pancreatitis in a tertiary hospital: A retrospective study. British Journal of Clinical Pharmacology 89:9, pages 2788-2797.
Crossref
Crossref
Jakub Rok, Justyna Kowalska, Zuzanna Rzepka, Dominika Stencel, Anna Skorek, Klaudia Banach & Dorota Wrześniok. (2023) The Assessment of Anti-Melanoma Potential of Tigecycline—Cellular and Molecular Studies of Cell Proliferation, Apoptosis and Autophagy on Amelanotic and Melanotic Melanoma Cells. Cells 12:12, pages 1564.
Crossref
Crossref
Can Wang, Jingshuang Wang, Juan Yan, Feng Chen, Ying Zhang & Xuelian Hu. (2023) Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum: hidden pathogens in peritoneal dialysis-associated peritonitis. International Journal of Infectious Diseases 131, pages 13-15.
Crossref
Crossref
Kuang-Yao Yang, Chung-Kan Peng, Chau-Chyun Sheu, Yu-Chao Lin, Ming-Cheng Chan, Sheng-Huei Wang, Chia-Min Chen, Chih-Yu Chen, Zhe-Rong Zheng & Jia-Yih Feng. (2023) Clinical effectiveness of tigecycline in combination therapy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective multi-centre observational study. Journal of Intensive Care 11:1.
Crossref
Crossref
Carmi Bartal, Kenneth V. I. Rolston & Lior Nesher. (2022) Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options. Infectious Diseases and Therapy 11:2, pages 683-694.
Crossref
Crossref
Soma Gaur & Abhijit M Bal. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
136
153
.
Aura Rusu & Emanuela Lorena Buta. (2021) The Development of Third-Generation Tetracycline Antibiotics and New Perspectives. Pharmaceutics 13:12, pages 2085.
Crossref
Crossref
Haijie Zhang, Yan Li, Yongjia Jiang, Xiaoyu Lu, Ruichao Li, Daxin Peng, Zhiqiang Wang & Yuan Liu. (2021)
Rapid and Accurate Antibiotic Susceptibility Determination of
tet
(X)-Positive E. coli Using RNA Biomarkers
. Microbiology Spectrum 9:2.
Crossref
Crossref
Bercemhan Yazirli, Emre Kara, Ahmet Cagkan Inkaya, Sarpcan Maden, Ugur Ozberk, Tolga Yildirim, Erkan Parlak, Omrum Uzun, Seref Rahmi Yilmaz & Mustafa Arici. (2021) A case report of tigecycline induced acute pancreatitis in a renal transplant patient and review of the literature: Should we avoid tigecycline in patients on calcineurin inhibitors?. Transplant Infectious Disease 23:4.
Crossref
Crossref
Tsuneyuki Ubagai, Yoshinori Sato, Go Kamoshida, Yuka Unno & Yasuo Ono. (2021) Immunomodulatory gene expression analysis in LPS-stimulated human polymorphonuclear leukocytes treated with antibiotics commonly used for multidrug-resistant strains. Molecular Immunology 129, pages 39-44.
Crossref
Crossref
Christian Eckmann & Hans-Jürgen Hain. 2021. Infektionen in der Allgemein- und Viszeralchirurgie. Infektionen in der Allgemein- und Viszeralchirurgie
53
66
.
Ian Morrissey, Melanie Olesky, Stephen Hawser, Sibylle H. Lob, James A. Karlowsky, G. Ralph Corey, Matteo Bassetti & Corey Fyfe. (2020)
In Vitro
Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
. Antimicrobial Agents and Chemotherapy 64:3.
Crossref
Crossref
George G. Zhanel, Jenine Esquivel, Sheryl Zelenitsky, Courtney K. Lawrence, Heather J. Adam, Alyssa Golden, Rachel Hink, Liam Berry, Frank Schweizer, Michael A. Zhanel, Denice Bay, Philippe R. S. Lagacé-Wiens, Andrew J. Walkty, Joseph P. LynchIIIIII & James A. Karlowsky. (2020) Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent. Drugs 80:3, pages 285-313.
Crossref
Crossref
Magdalena Skarżyńska, Magdalena Zając & Dariusz Wasyl. (2020) Antibiotics And Bacteria: Mechanisms Of Action And Resistance Strategies. Postępy Mikrobiologii - Advancements of Microbiology 59:1, pages 49-62.
Crossref
Crossref
Martin Vestergaard, Dorte Frees & Hanne Ingmer. 2019. Gram-Positive Pathogens. Gram-Positive Pathogens
747
765
.
Martin Vestergaard, Dorte Frees & Hanne Ingmer. (2019) Antibiotic Resistance and the MRSA Problem. Microbiology Spectrum 7:2.
Crossref
Crossref
George G. Zhanel, Melanie R. Baxter, Heather J. Adam, Joyce Sutcliffe & James A. Karlowsky. (2018) In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014–2015. Diagnostic Microbiology and Infectious Disease 91:1, pages 55-62.
Crossref
Crossref
Robert S. Daum. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
692
706.e4
.
Refaat Boushra Maria, Ali Ibrahem Reham, Fadl Gad Gamal & Mohammed Mohi El-Din Hassan. (2017) In vitro efficacies and durabilities of antibiotic/vitamin C coated hemodialysis catheters. African Journal of Microbiology Research 11:25, pages 1043-1050.
Crossref
Crossref
Yongbo Zhang, Peizhen Li, Yuhan Yin, Fuqiang Li & Qinghua Zhang. (2016) In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates. The Journal of Antibiotics 70:2, pages 193-195.
Crossref
Crossref
Terry King-Wing Ma, Chi Bon Leung, Kai Ming Chow, Bonnie Ching-Ha Kwan, Philip Kam-Tao Li & Cheuk Chun Szeto. (2016) Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis. Clinical Kidney Journal 9:4, pages 616-623.
Crossref
Crossref
Yin Yuhan, Yue Ziyun, Zhang Yongbo, Li Fuqiang & Zhang Qinghua. (2016) Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae. Revista da Sociedade Brasileira de Medicina Tropical 49:2, pages 165-171.
Crossref
Crossref
George G. Zhanel, Doris Cheung, Heather Adam, Sheryl Zelenitsky, Alyssa Golden, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Andrew Walkty, Alfred S. Gin, Daryl J. Hoban & James A. Karlowsky. (2016) Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent. Drugs 76:5, pages 567-588.
Crossref
Crossref
Wentao Ni, Yuliang Han, Jie Liu, Chuanqi Wei, Jin Zhao, Junchang Cui, Rui Wang & Youning Liu. (2016) Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections. Medicine 95:11, pages e3126.
Crossref
Crossref
Wentao Ni, Yuliang Han, Jin Zhao, Chuanqi Wei, Junchang Cui, Rui Wang & Youning Liu. (2016) Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. International Journal of Antimicrobial Agents 47:2, pages 107-116.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
2
4
.
Matthew Moffa & Itzhak Brook. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
322
338.e6
.
Giampaolo BucaneveAlessandra MicozziMarco PicardiStelvio BallantiNicola CascavillaPrassede SalutariGiorgina SpecchiaRosa FanciMario LuppiLaura CudilloRenato CantaffaGiuseppe MiloneMonica BocchiaGiovanni MartinelliMassimo OffidaniAnna ChierichiniFrancesco FabbianoGiovanni QuartaValeria PrimonBruno MartinoAnnunziata MannaEliana ZuffaAntonella FerrariGiuseppe GentileRobin FoàAlbano Del Favero. (2014) Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin/Tazobactam and Tigecycline in High-Risk Hematologic Patients With Cancer With Febrile Neutropenia. Journal of Clinical Oncology 32:14, pages 1463-1471.
Crossref
Crossref
Sanath Kumar, Mun Mun Mukherjee & Manuel F. Varela. (2013) Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily. International Journal of Bacteriology 2013, pages 1-15.
Crossref
Crossref
Nathalie Dartois, C Angel Cooper, Nathalie Castaing, Hassan Gandjini & Denise Sarkozy. (2013) Tigecycline Versus Levofloxacin in Hospitalized Patients
With Community-Acquired Pneumonia: An Analysis of
Risk Factors. The Open Respiratory Medicine Journal 7:1, pages 13-20.
Crossref
Crossref
Mohammad D. Mansouri, Richard A. Hull, Charles E. Stager, Richard M. Cadle & Rabih O. Darouiche. (2013)
In Vitro
Activity and Durability of a Combination of an Antibiofilm and an Antibiotic against Vascular Catheter Colonization
. Antimicrobial Agents and Chemotherapy 57:1, pages 621-625.
Crossref
Crossref
Halichidis Stela. (2012) Tigecycline For Skin Infection With SIRS In Immunocompromised Host. ARS Medica Tomitana 18:2, pages 77-79.
Crossref
Crossref
R. Cockeran, N. D. Mutepe, A. J. Theron, G. R. Tintinger, H. C. Steel, P. I. Stivaktas, G. A. Richards, C. Feldman & R. Anderson. (2011) Calcium-dependent potentiation of the pro-inflammatory functions of human neutrophils by tigecycline in vitro. Journal of Antimicrobial Chemotherapy 67:1, pages 130-137.
Crossref
Crossref
Robert S. Daum. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
675
689.e6
.
Zhangjing Chen, Jufang Wu, Yingyuan Zhang, Junming Wei, Xisheng Leng, Jianwei Bi, Rong Li, Lunan Yan, Zhiwei Quan, Xiaoping Chen, Yunsong Yu, Zhiyong Wu, Dawei Liu, Xiaochun Ma, Robert Maroko & Angel Cooper. (2010) Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infectious Diseases 10:1.
Crossref
Crossref
Amsterdam. (2010) Antimicrobial Susceptibility of Bloodstream Isolates of <i>Staphylococcus aureus</i>: Global Results from the Tigecycline Evaluation and Surveillance Trial, 2004-2008. American Journal of Infectious Diseases 6:1, pages 1-7.
Crossref
Crossref
Tore Midtvedt. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
445
460
.
G. G. Zhanel, P. J. Baudry, F. Tailor, L. Cox, D. J. Hoban & J. A. Karlowsky. (2009) Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum -lactamases, AmpC -lactamases and reduced susceptibility to carbapenems using an in vitro model. Journal of Antimicrobial Chemotherapy 64:4, pages 824-828.
Crossref
Crossref
Roy F. Chemaly, Santosh S. Hanmod, Ying Jiang, Dhanesh B. Rathod, Victor Mulanovich, Javier A. Adachi, Kenneth V. Rolston, Issam I. Raad & Ray Y. Hachem. (2009) Tigecycline Use in Cancer Patients With Serious Infections. Medicine 88:4, pages 211-220.
Crossref
Crossref
George G. Zhanel, Grace Sniezek, Frank Schweizer, Sheryl Zelenitsky, Philippe R.S. Lagacé-Wiens, Ethan Rubinstein, Alfred S. Gin, Daryl J. Hoban & James A. Karlowsky. (2009) Ceftaroline. Drugs 69:7, pages 809-831.
Crossref
Crossref
Pranatharthi H. Chandrasekar & George Alangaden. 2010. Managing Infections in Patients With Hematological Malignancies. Managing Infections in Patients With Hematological Malignancies
71
112
.
I. Florescu, M. Beuran, R. Dimov, A. Razbadauskas, M. Bochan, G. Fichev, G. Dukart, T. Babinchak, C. A. Cooper, E. J. Ellis-Grosse, N. Dartois & H. Gandjini. (2008) Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. Journal of Antimicrobial Chemotherapy 62:suppl_1, pages i17-i28.
Crossref
Crossref
Jacob Gilad & Yehuda Carmeli. (2008) Treatment Options for??Multidrug-Resistant Acinetobacter Species. Drugs 68:2, pages 165-189.
Crossref
Crossref
Almudena Burillo & Emilio Bouza. (2008) Papel de las bacterias grampositivas en la infección intraabdominal. Enfermedades Infecciosas y Microbiología Clínica 26, pages 61-68.
Crossref
Crossref
Gina S. Lowell & Robert S. Daum. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
679
693
.
Carlos Rubio Terrés. (2013) Análisis farmacoeconómico del tratamiento de las infecciones complicadas de piel y tejidos blandos con tigeciclina o la combinación de vancomicina y aztreonam en España. PharmacoEconomics Spanish Research Articles 5:1, pages 23-33.
Crossref
Crossref
Julie L Chen, Jose Orsini & Claude Killu. (2016) Poor Central Nervous System Penetration of Tigecycline in a Patient with Sepsis and Ventriculitis Caused by Multidrug-Resistant Klebsiella Pneumoniae. Journal of Pharmacy Technology 23:6, pages 344-348.
Crossref
Crossref
Gerald A. Denys, Kim M. Koch & Michael J. Dowzicky. (2007) Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. American Journal of Infection Control 35:8, pages 521-526.
Crossref
Crossref
Kevin Outterson, Julie Balch Samora & Karen Keller-Cuda. (2007) Will longer antimicrobial patents improve global public health?. The Lancet Infectious Diseases 7:8, pages 559-566.
Crossref
Crossref
Michael W Daly, David J Riddle, Nathan A Ledeboer, W. Michael Dunne & David J Ritchie. (2007)
Tigecycline for Treatment of Pneumonia and Empyema Caused by Carbapenemase-Producing
Klebsiella pneumoniae
. Pharmacotherapy 27:7, pages 1052-1057.
Crossref
Crossref
N. Mesaros, P. Nordmann, P. Plésiat, M. Roussel-Delvallez, J. Van Eldere, Y. Glupczynski, Y. Van Laethem, F. Jacobs, P. Lebecque, A. Malfroot, P.M. Tulkens & F. Van Bambeke. (2007) Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clinical Microbiology and Infection 13:6, pages 560-578.
Crossref
Crossref
S. Swoboda, T. Hoppe-Tichy, H.K. Geiss, C. Hainer, T.H. Nguyen, H.-P. Knaebel & M.A. Weigand. (2007) Septischer Schock durch Vancomycin-resistente EnterokokkenSeptic shock due to vancomycin-resistant enterococci infection. Der Anaesthesist 56:2, pages 169-174.
Crossref
Crossref
Burke A. Cunha. (2006) Antimicrobial Therapy of Multidrug-Resistant Streptococcus pneumoniae, Vancomycin-Resistant Enterococci, and Methicillin-Resistant Staphylococcus aureus. Medical Clinics of North America 90:6, pages 1165-1182.
Crossref
Crossref
María-Isabel Morosini, María García-Castillo, Teresa M. Coque, Aránzazu Valverde, Ângela Novais, Elena Loza, Fernando Baquero & Rafael Cantón. (2006)
Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing
Enterobacteriaceae
and In Vitro Activity of Tigecycline
. Antimicrobial Agents and Chemotherapy 50:8, pages 2695-2699.
Crossref
Crossref
Paolo GrossiDaniela Dalla Gasperina. (2006) Antimicrobial Treatment of Sepsis. Surgical Infections 7:supplement 2, pages s-87-s-91.
Crossref
Crossref
R. Zaragoza-Crespo & J.I. Blanes-Mompó. (2006) Infección y pie diabético. ¿Existen nuevas posibilidades terapéuticas?. Angiología 58:5, pages 347-356.
Crossref
Crossref